OWLT
Owlet, Inc.
NYSE · Healthcare · Medical - Devices · US
$4.16
+1.22%Year over year
Reported trailing growth
- Revenue
- +28.0%
- EBITDA
- +88.2%
- EBIT
- +55.6%
- EPS
- +87.4%
- Free cash flow
- +30.1%
- Operating cash flow
- +38.7%
Forward estimates
Based on analyst estimates
- Revenue
- +16.5%
- EBITDA
- +149.7%
- EPS
- +88.8%
Three-year CAGR
- Revenue
- +15.2%
- EBITDA
- —
- EBIT
- +59.1%
- Net income
- —
- EPS
- -44.5%
- Free cash flow
- +7.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026